Want to see CPMD full AI Analyst Report?
CPMD Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume1.40K
Average Volume (3M)N/A
Market Cap
$1.70M
Enterprise Value$22.67M
Total Cash (Recent Filing)$555.00
Total Debt (Recent Filing)$20.63M
Price to Earnings (P/E)―
Beta-0.47
Next Earnings
May 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding708,689,900
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-0.11
Price to Sales (P/S)2.53
P/FCF Ratio-4.34
Enterprise Value/Market Cap13.33
Enterprise Value/Revenue13.34
Enterprise Value/Gross Profit-15.02
Enterprise Value/Ebitda-2.88
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRapid revenue growth indicates improving commercial traction and customer adoption. Although growth comes from a small base, continued expansion could strengthen the operating platform if the company converts sales into healthier gross margins.
Improving Cash FlowThe shift from negative to modestly positive operating and free cash flow suggests improved working-capital management or lower cash burn. Sustained cash generation would reduce reliance on external funding and support operational continuity.
Reduced Cash BurnImproved cash discipline is a constructive operational signal because it may provide management with more time to address weak profitability. If maintained through cost control, it could improve financial resilience even before earnings turn positive.
Bears Say
Persistent Negative EquityA persistent equity deficit indicates accumulated losses have overwhelmed the capital structure. This weakens financial flexibility, limits access to conventional financing and increases the likelihood of dilution or restructuring over the medium term.
Severe UnprofitabilityNegative gross profit and losses that exceed revenue point to fundamentally unsustainable unit economics and a heavy cost structure. Revenue growth alone may not create value unless pricing, production economics and operating expenses improve materially.
Refinancing DependenceSignificant debt combined with negative equity increases refinancing risk and reduces room to absorb setbacks. Continued operations may require additional capital, exposing shareholders to dilution and the business to higher funding constraints.
Cannapharmarx News
CPMD FAQ
What was Cannapharmarx Inc’s price range in the past 12 months?
Currently, no data Available
What is Cannapharmarx Inc’s market cap?
Cannapharmarx Inc’s market cap is $1.70M.
When is Cannapharmarx Inc’s upcoming earnings report date?
Cannapharmarx Inc’s upcoming earnings report date is May 25, 2027 which is in 258 days.
How were Cannapharmarx Inc’s earnings last quarter?
Cannapharmarx Inc released its earnings results on May 19, 2026. The company reported -$0.001 earnings per share for the quarter.
Is Cannapharmarx Inc overvalued?
According to Wall Street analysts Cannapharmarx Inc’s price is currently Overvalued.
Does Cannapharmarx Inc pay dividends?
Cannapharmarx Inc does not currently pay dividends.
What is Cannapharmarx Inc’s EPS estimate?
Cannapharmarx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannapharmarx Inc have?
Cannapharmarx Inc has 708,689,900 shares outstanding.
What happened to Cannapharmarx Inc’s price movement after its last earnings report?
Cannapharmarx Inc reported an EPS of -$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cannapharmarx Inc?
Currently, no hedge funds are holding shares in CPMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cannapharmarx Inc
CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.